178 related articles for article (PubMed ID: 23365645)
1. Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.
Mountzios G; Kostopoulos I; Kotoula V; Sfakianaki I; Fountzilas E; Markou K; Karasmanis I; Leva S; Angouridakis N; Vlachtsis K; Nikolaou A; Konstantinidis I; Fountzilas G
PLoS One; 2013; 8(1):e54048. PubMed ID: 23365645
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.
Dionysopoulos D; Pavlakis K; Kotoula V; Fountzilas E; Markou K; Karasmanis I; Angouridakis N; Nikolaou A; Kalogeras KT; Fountzilas G
Strahlenther Onkol; 2013 Mar; 189(3):202-14. PubMed ID: 23400686
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
Dziadziuszko R; Merrick DT; Witta SE; Mendoza AD; Szostakiewicz B; Szymanowska A; Rzyman W; Dziadziuszko K; Jassem J; Bunn PA; Varella-Garcia M; Hirsch FR
J Clin Oncol; 2010 May; 28(13):2174-80. PubMed ID: 20351332
[TBL] [Abstract][Full Text] [Related]
4. Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer.
Krikelis D; Kotoula V; Bobos M; Fountzilas E; Markou K; Karasmanis I; Angouridakis N; Vlachtsis K; Kalogeras KT; Nikolaou A; Fountzilas G
Anticancer Res; 2014 Nov; 34(11):6495-503. PubMed ID: 25368251
[TBL] [Abstract][Full Text] [Related]
5. IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer.
Hirakawa T; Yashiro M; Murata A; Hirata K; Kimura K; Amano R; Yamada N; Nakata B; Hirakawa K
BMC Cancer; 2013 Aug; 13():392. PubMed ID: 23962053
[TBL] [Abstract][Full Text] [Related]
6. High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer.
Zaanan A; Calmel C; Henriques J; Svrcek M; Blons H; Desbois-Mouthon C; Merabtene F; Goumard C; Parc Y; Gayet B; Taieb J; Validire P; Louvet C; Fléjou JF; Le Bouc Y; Praz F
Cell Oncol (Dordr); 2020 Apr; 43(2):237-247. PubMed ID: 31823290
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular prognostic factors in operable laryngeal cancer.
Vlachtsis K; Nikolaou A; Markou K; Fountzilas G; Daniilidis I
Eur Arch Otorhinolaryngol; 2005 Nov; 262(11):890-8. PubMed ID: 15739081
[TBL] [Abstract][Full Text] [Related]
8. Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients.
Ludovini V; Flacco A; Bianconi F; Ragusa M; Vannucci J; Bellezza G; Chiari R; Minotti V; Pistola L; Tofanetti FR; Siggillino A; Baldelli E; Sidoni A; Daddi N; Puma F; Varella-Garcia M; Crinò L
Cancer Chemother Pharmacol; 2013 Mar; 71(3):671-80. PubMed ID: 23314677
[TBL] [Abstract][Full Text] [Related]
9. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma.
Ye P; Qu CF; Hu XL
Tumour Biol; 2016 May; 37(5):6893-904. PubMed ID: 26662570
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.
Starska K; Forma E; Lewy-Trenda I; Stasikowska-Kanicka O; Skóra M; Bryś M
Cell Oncol (Dordr); 2018 Jun; 41(3):253-268. PubMed ID: 29299828
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.
Fountzilas E; Kotoula V; Angouridakis N; Karasmanis I; Wirtz RM; Eleftheraki AG; Veltrup E; Markou K; Nikolaou A; Pectasides D; Fountzilas G
PLoS One; 2013; 8(8):e70429. PubMed ID: 23950933
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancer.
Vilmar A; Santoni-Rugiu E; Cillas JG; Huarriz M; Sørensen JB
Anticancer Res; 2014 Jun; 34(6):2991-6. PubMed ID: 24922664
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer.
Chang MH; Lee J; Han J; Park YH; Ahn JS; Park K; Ahn MJ
APMIS; 2009 Dec; 117(12):861-9. PubMed ID: 20078550
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes.
Mountzios G; Aivazi D; Kostopoulos I; Kourea HP; Kouvatseas G; Timotheadou E; Zebekakis P; Efstratiou I; Gogas H; Vamvouka C; Chrisafi S; Stofas A; Pentheroudakis G; Koutras A; Galani E; Bafaloukos D; Fountzilas G
PLoS One; 2014; 9(3):e91407. PubMed ID: 24637962
[TBL] [Abstract][Full Text] [Related]
15. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
16. Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.
Hartog H; Horlings HM; van der Vegt B; Kreike B; Ajouaou A; van de Vijver MJ; Marike Boezen H; de Bock GH; van der Graaf WT; Wesseling J
Breast Cancer Res Treat; 2011 Oct; 129(3):725-36. PubMed ID: 21107683
[TBL] [Abstract][Full Text] [Related]
17. High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
Gately K; Forde L; Cuffe S; Cummins R; Kay EW; Feuerhake F; O'Byrne KJ
Clin Lung Cancer; 2014 Jan; 15(1):58-66. PubMed ID: 24210543
[TBL] [Abstract][Full Text] [Related]
18. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
[TBL] [Abstract][Full Text] [Related]
19. Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynx.
Pentheroudakis G; Nicolaou I; Kotoula V; Fountzilas E; Markou K; Eleftheraki AG; Fragkoulidi A; Karasmanis I; Tsigka A; Angouridakis N; Vlachtsis K; Nikolaou A; Pavlidis N; Fountzilas G
Oral Oncol; 2012 Aug; 48(8):709-16. PubMed ID: 22366437
[TBL] [Abstract][Full Text] [Related]
20. Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas.
Gallardo A; Lerma E; Escuin D; Tibau A; Muñoz J; Ojeda B; Barnadas A; Adrover E; Sánchez-Tejada L; Giner D; Ortiz-Martínez F; Peiró G
Br J Cancer; 2012 Apr; 106(8):1367-73. PubMed ID: 22454081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]